STUDIES.
SCIENTIFIC RESEARCH
IN FOCUS.
NOA-17/GlioCave-Trial (a phase 2 study on adjuvant stereotactic fractionated radiotherapy of the resection cavity in recurrent glioblastoma)
NOA-17/GlioCave-Trial (a phase 2 study on adjuvant stereotactic fractionated radiotherapy of the resection cavity in recurrent glioblastoma)
In the multicenter, randomized phase 2 study “GlioCave”, the efficacy of adjuvant radiotherapy of the resection cavity after complete resection of a glioblastoma recurrence was investigated. Radiotherapy of the resection cavity with 36 à 3 Gy or 46 à 2 Gy was compared with further control.